LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA, FASTCT, stands as a beacon of excellence in oncology pharmacy, exemplifying the critical role pharmacists play in patient-centered cancer care at Atrium Health Wake Forest Baptist. Her work highlights a deeply collaborative environment where pharmacists are integral to bridging inpatient and ambulatory care, significantly advancing clinical practice and research both locally and nationally.

The collaborative culture at Atrium Health Wake Forest Baptist fosters seamless transitions of care, ensuring comprehensive support for both inpatients and ambulatory patients. Pharmacists work closely with nurses and physicians to provide unparalleled education and support, ensuring a unified approach to patient well-being that truly makes the team feel like a cohesive family committed to exceptional patient outcomes.

Significant opportunities abound for oncology pharmacists to engage in clinical research, particularly through the institution’s robust residency program. With four oncology pharmacy residents each year, four distinct research projects are undertaken, allowing experienced pharmacists to mentor new practitioners while continually evaluating new therapies, assessing guideline changes, and exploring their impact on patient outcomes.

Beyond internal initiatives, there is a strong emphasis on collaborative research with other institutions. This expanded focus aims to compare diverse clinical practices and disseminate findings on a larger scale, thereby enriching the collective knowledge base and driving advancements in oncology pharmacy globally and through robust clinical research endeavors.

A core tenet of Dr. Kennedy’s philosophy is the continuous promotion and demonstration of the oncology pharmacist’s value. This involves proactive engagement with patients, nurses, and providers to highlight their expertise in patient education, symptom management, and critical decision-making processes. Effective marketing of these pharmacist roles is essential for broader recognition and appreciation.

Furthermore, demonstrating value extends to actively promoting and publishing clinical research. By presenting their findings, oncology pharmacists can educate the wider medical community and public, dispelling misconceptions and solidifying their image as crucial advocates dedicated to ensuring every patient receives optimal cancer care with minimal side effects and the best possible outcomes.

Dr. Kennedy’s career also illustrates diverse pathways in healthcare leadership, both within Atrium Health and through prominent professional organizations like the Hematology/Oncology Pharmacy Association (HOPA). These experiences forge invaluable connections and provide a panoramic view of oncology pharmacy practice, underscoring the power of collective action in advancing patient advocacy and the profession as a whole.